thiorphan has been researched along with Granulocytic Leukemia in 1 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stanović, S | 1 |
| Boranić, M | 1 |
| Petrovecki, M | 1 |
| Batinić, D | 1 |
| Skodlar, J | 1 |
| Nemet, D | 1 |
| Labar, B | 1 |
1 other study available for thiorphan and Granulocytic Leukemia
| Article | Year |
|---|---|
Thiorphan, an inhibitor of neutral endopeptidase/enkephalinase (CD10/CALLA) enhances cell proliferation in bone marrow cultures of patients with acute leukemia in remission.
Topics: Acute Disease; Anemia, Refractory, with Excess of Blasts; Angiotensin-Converting Enzyme Inhibitors; | 2000 |